Chi-Chung Li is a highly accomplished professional in the field of pharmacokinetics and drug development, with extensive experience in both preclinical and clinical settings. With roles at Merck Research Laboratories from 2007 to 2012, including Senior Research Pharmacokineticist, Research Fellow, and Associate Principal Scientist, Chi-Chung developed population modeling strategies and spearheaded multidisciplinary drug development teams. Subsequent positions at Genentech included Senior Principal Scientist and Principal Scientist, focusing on clinical pharmacology for T-cell dependent bispecific antibodies and cancer immunotherapies. Chi-Chung's academic background includes a PhD in Chemical Engineering from the University of Florida, where research on ophthalmic drug delivery gained notable recognition.
This person is not in the org chart
This person is not in any teams
This person is not in any offices